SCHEMBL22423967

SCHEMBL22423967

CC(C)Nc1nc2c(c(=O)[nH]1)C[C@@H](C)N(C(=O)c1ccc(Cl)c(Cl)c1)C2

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 18/20 0.41
▸ HPGD P15428 1/20 0.37
▸ PGR P06401 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24275948 0.90 P2RX7 (0.41) P2RX7PGR
SCHEMBL22423965 0.81 P2RX7 (0.40) P2RX7HPGDPGR
SCHEMBL22424334 0.81 HPGD (0.46) HPGD
SCHEMBL22424564 0.81 CLPP (0.49) HPGD
SCHEMBL22424344 0.81 CLPP (0.49) HPGD
SCHEMBL22424223 0.81 CLPP (0.49) HPGD
SCHEMBL22410811 0.77 P2RX7 (0.37) P2RX7PGR
SCHEMBL22410812 0.77 P2RX7 (0.37) P2RX7PGR
SCHEMBL22423976 0.77 P2RX7 (0.36) P2RX7
SCHEMBL22424211 0.77 P2RX7 (0.36) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020182990-A1 FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2020-09-17 — — WO disclosed
Send feedback